The Role of Immunotherapy to Overcome Resistance in Viral-Associated Head and Neck Cancer

被引：5
|
作者：
Pharaon, Rebecca R. [1 ]
Xing, Yan [1 ]
Agulnik, Mark [1 ]
Villaflor, Victoria M. [1 ]
机构：
[1] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA
来源：
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词：
immunotherapy; head and neck cancer; oropharyngeal squamous cell carcinoma; nasopharyngeal carcinoma; viral-associated cancers; human papillomavirus; Epstein-Barr virus; SQUAMOUS-CELL CARCINOMA; EPSTEIN-BARR-VIRUS; PHASE-II TRIAL; HUMAN-PAPILLOMAVIRUS; NASOPHARYNGEAL CARCINOMA; OPEN-LABEL; OROPHARYNGEAL CANCER; ANTITUMOR-ACTIVITY; METASTATIC HEAD; PLUS CETUXIMAB;
D O I：
10.3389/fonc.2021.649963
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A subset of head and neck cancers arising in the oropharynx and the nasopharynx are associated with human papillomavirus or Epstein-Barr virus. Unfortunately, limited treatment options exist once patients develop recurrent or metastatic disease in these cancers. Interest has risen in utilizing novel strategies including combination immune checkpoint inhibitors, vaccines, and adoptive cellular therapy, to improve treatment response and outcomes. Several ongoing studies are investigating the potential to overcome resistance to standard of care chemoradiation therapy with monotherapy or combination immunotherapy strategies in these viral-associated head and neck cancers.
引用
收藏
页数：12
相关论文
共 50 条
  • [1] Meet the Insidious Players: Review of Viral Infections in Head and Neck Cancer Etiology with an Update on Clinical Trials
    Mahmutovic, Lejla
    Bilajac, Esma
    Hromic-Jahjefendic, Altijana
    MICROORGANISMS, 2021, 9 (05)
  • [2] Immunotherapy Approaches in HPV-Associated Head and Neck Cancer
    Julian, Ricklie
    Savani, Malvi
    Bauman, Julie E.
    CANCERS, 2021, 13 (23)
  • [3] The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
    Cohen, Ezra E. W.
    Bell, R. Bryan
    Bifulco, Carlo B.
    Burtness, Barbara
    Gillison, Maura L.
    Harrington, Kevin J.
    Quynh-Thu Le
    Lee, Nancy Y.
    Leidner, Rom
    Lewis, Rebecca L.
    Licitra, Lisa
    Mehanna, Hisham
    Mel, Loren K.
    Raben, Adam
    Sikora, Andrew G.
    Uppaluri, Ravindra
    Whitworth, Fernanda
    Zandberg, Dan P.
    Ferris, Robert L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [4] Immunotherapy for Head and Neck Cancer
    Trivedi, Sumita
    Sun, Lova
    Aggarwal, Charu
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (05) : 1021 - 1037
  • [5] Immunotherapy for head and neck cancer: Present and future
    Fasano, Morena
    Della Corte, Carminia Maria
    Di Liello, Raimondo
    Viscardi, Giuseppe
    Sparano, Francesca
    Iacovino, Maria Lucia
    Paragliola, Fernando
    Piccolo, Antonio
    Napolitano, Stefania
    Martini, Giulia
    Morgillo, Floriana
    Cappabianca, Salvatore
    Ciardiello, Fortunato
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 174
  • [6] Role of Immunotherapy in Head and Neck Cancer
    Ling, Diane C.
    Bakkenist, Chris J.
    Ferris, Robert L.
    Clump, David A.
    SEMINARS IN RADIATION ONCOLOGY, 2018, 28 (01) : 12 - 16
  • [7] Revealing the viral culprits: the hidden role of the oral virome in head and neck cancers
    Salem, Abdelhakim
    ARCHIVES OF MICROBIOLOGY, 2025, 207 (04)
  • [8] Immunotherapy in Head and Neck Cancer: Where Do We Stand?
    Vallianou, Natalia G.
    Evangelopoulos, Angelos
    Kounatidis, Dimitris
    Panagopoulos, Fotis
    Geladari, Eleni
    Karampela, Irene
    Stratigou, Theodora
    Dalamaga, Maria
    CURRENT ONCOLOGY REPORTS, 2023, 25 (08) : 897 - 912
  • [9] Immunotherapy in head and neck cancer
    Ye, Xuemei
    Costantini, Carrie
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 (01) : 48 - 55
  • [10] Immunotherapy for Head and Neck Cancer
    Sim, Felix
    Leidner, Rom
    Bell, Richard Bryan
    ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA, 2019, 31 (01) : 85 - +
12345